Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9I0I
|
||||
| Drug Name |
(S)-N-(3-(3-chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl)-2-methylbenzamide
|
||||
| Synonyms |
CHEMBL572332
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H18ClN3O2
|
||||
| Canonical SMILES |
Cc1ccccc1C(=O)N[C@@H](Cc2cccc(Cl)c2)C(=O)NCC#N
|
||||
| InChI |
InChI=1S/C19H18ClN3O2/c1-13-5-2-3-8-16(13)18(24)23-17(19(25)22-10-9-21)12-14-6-4-7-15(20)11-14/h2-8,11,17H,10,12H2,1H3,(H,22,25)(H,23,24)/t17-/m0/s1
|
||||
| InChIKey |
UTKYXGXWEJOOHR-KRWDZBQOSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.